Literature DB >> 3690370

Anxiogenic effects in benzodiazepine withdrawal are linked to the development of tolerance.

S E File1, H A Baldwin, K Aranko.   

Abstract

Rats were tested in the elevated plus-maze test of anxiety after a probe injection of chlordiazepoxide (CDP 5 mg/kg) following short-term (5 days) or long-term (20 days) pretreatment with 5 or 20 mg/kg/day. After short-term pretreatment with either dose, the probe dose had anxiolytic effects (it increased the % number of entries, and % of time spent, on the open arms). After long-term pretreatment with either dose of CDP there was tolerance to these effects. When the rats were tested 24 hours after their last dose of CDP, there was no indication of spontaneous withdrawal responses in the rats from the short-term pretreatment groups, but the rats in the long-term pretreatment groups showed increased anxiety (decreases in the % number of entries, and the % of time spent, on the open arms, compared with controls). These results support suggestions that the development of tolerance and the incidence of withdrawal anxiety may both be manifestations of the underlying changes occurring during drug dependence.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3690370     DOI: 10.1016/0361-9230(87)90079-7

Source DB:  PubMed          Journal:  Brain Res Bull        ISSN: 0361-9230            Impact factor:   4.077


  11 in total

1.  Characterisation of the phenomenon of "one-trial tolerance" to the anxiolytic effect of chlordiazepoxide in the elevated plus-maze.

Authors:  S E File; P S Mabbutt; P K Hitchcott
Journal:  Psychopharmacology (Berl)       Date:  1990       Impact factor: 4.530

2.  Anxiogenic-like action of caerulein, a CCK-8 receptor agonist, in the mouse: influence of acute and subchronic diazepam treatment.

Authors:  J Harro; M Põld; E Vasar
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1990 Jan-Feb       Impact factor: 3.000

3.  βCCT, an antagonist selective for α(1)GABA(A) receptors, reverses diazepam withdrawal-induced anxiety in rats.

Authors:  Jovana Divljaković; Marija Milić; Ojas A Namjoshi; Veera V Tiruveedhula; Tamara Timić; James M Cook; Miroslav M Savić
Journal:  Brain Res Bull       Date:  2012-11-10       Impact factor: 4.077

4.  Neuropharmacology of a new potential anxiolytic compound, F 2692, 1-(3'-trifluoromethyl phenyl) 1, 4-dihydro 3-amino 4-oxo 6-methyl pyridazine. 2. Evaluation of its tolerance and dependence producing potential and of its effects on benzodiazepine withdrawal in the elevated plus-maze test in rats.

Authors:  P Chopin; M B Assié; M Briley
Journal:  Psychopharmacology (Berl)       Date:  1993       Impact factor: 4.530

5.  Sex differences in diazepam effects and parvalbumin-positive GABA neurons in trait anxiety Long Evans rats.

Authors:  Rebecca Ravenelle; Nichole M Neugebauer; Timothy Niedzielak; S Tiffany Donaldson
Journal:  Behav Brain Res       Date:  2014-05-06       Impact factor: 3.332

6.  Diazepam withdrawal responses measured in the social interaction test of anxiety and their reversal by baclofen.

Authors:  S E File; P S Mabbutt; N Andrews
Journal:  Psychopharmacology (Berl)       Date:  1991       Impact factor: 4.530

7.  Effects of nicotine and a cannabinoid receptor agonist on negative contrast: distinction between anxiety and disappointment?

Authors:  Rachel F Genn; S Tucci; S Parikh; S E File
Journal:  Psychopharmacology (Berl)       Date:  2004-06-16       Impact factor: 4.530

8.  Elevated startle during withdrawal from acute morphine: a model of opiate withdrawal and anxiety.

Authors:  Andrew C Harris; Jonathan C Gewirtz
Journal:  Psychopharmacology (Berl)       Date:  2003-09-10       Impact factor: 4.530

9.  Flumazenil prevents the development of chlordiazepoxide withdrawal in rats tested in the social interaction test of anxiety.

Authors:  H A Baldwin; S E File
Journal:  Psychopharmacology (Berl)       Date:  1989       Impact factor: 4.530

10.  A theory of benzodiazepine dependence that can explain whether flumazenil will enhance or reverse the phenomena.

Authors:  S E File; P K Hitchcott
Journal:  Psychopharmacology (Berl)       Date:  1990       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.